A microRNA is a tiny non-coding RNA molecule that is found in animals, plants as well as some viruses, that is utilized in post-transcriptional regulation of gene expression and RNA silencing. The overall market is likely to account for a robust growth owing to growing demand for microRNA re-agents in addition to kits for a range of applications which could in due course interpret into initial innovative therapeutic solutions for different difficult to cure illnesses. In terms of value, it is estimated to record a CAGR of XX% during the eight-year calculated period 2025.
Based on assay type, the overall market is segmented into miRNA Arrays, PCR-based assay, next-generation sequencing (NGS) and immune assay (which is further categorized into colorimetric assays, fluorescent assays and chemiluminescent assays). PCR based arrays segment will be accounting for 36.9% by the end of 2025, followed by next-generation sequencing segment and is estimated to record an XX% CAGR throughout the projection period.
Request for Report Sample: https://www.trendsmarketresearch.com/report/sample/3385
The application of the microRNA is mainly into research and clinical diagnostics. The research segment is considered as the biggest in the overall market by accounting for about US$ XX Million by the end of 2025, up from US$ XX Million in the year 2017. It is also expected to record an XX% CAGR over the calculated period.
The end users of the microRNA include biopharmaceutical companies, academic and research institutes, diagnostic centers and contract research organizations. The academic & research institutes are the most lucrative segment in overall microRNA market, it is expected to be accounting for about US$ XX Million by the end of the forecast year 2025, up from US$ XX Million in 2017 in terms of value. It is projected to register a CAGR of XX% throughout 2018-2025.
On the basis of region, the overall market is studied across five key regions including Latin America, North America, Asia Pacific, Europe and Middle East & Africa. North America is considered to be the most lucrative region among other regions and is likely to reach US$ XX Million by 2025, exhibiting a XX% CAGR during 2018-2025, followed by Europe.
Place a Direct Purchase Order @ https://www.trendsmarketresearch.com/checkout/3385/Single
Key Market Players
The overall market for microRNA has at present the following prominent players
• Agilent Technologies
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• Sigma Aldrich Corp.
• Thermo Fisher Scientific, Inc.
• Qiagen N.V
• Rosetta Genomics Ltd.
• HTG Molecular Diagnostics, Inc.
• Bio-Rad Laboratories Inc.
• Dharmacon, a Horizon Discovery Group Co.
• System Biosciences LLC
• Bioline GmbH (A Meridian Life Science Company)
• Miltenyi Biotec
• BioVendor — Laboratorní medicína a.s.
• Abcam Plc
• New England Biolabs, Inc.
• Kaneka Corporation (Eurogentec)
• Promega Corporation
• GeneCopoeia, Inc.
• NanoString Technologies, Inc
Get Request for Table of Contents: https://www.trendsmarketresearch.com/report/requesttoc/3385